U.S. Cancer Statistics Data Briefs

In 2019, a total of 224,733 new cases of prostate cancer were reported in the United States. The incidence rate was 112 per 100,000 males. Most cases of prostate cancer (70%) were diagnosed at the local stage.

In 2019, 142,462 cases of colon and rectum cancer were reported: 75,581 among males and 66,881 among females. The incidence rate was 36 per 100,000 standard population, and was 42 per 100,000 males and 32 per 100,000 females.

Incidence rates for cancers in adolescents and young adults increased from 1999 to 2019 in non-Hispanic American Indian and Alaska Native populations. Female breast, thyroid, male testicular, lymphomas, colorectal, and female cervical cancer were the most common cancers.

According to data from 2015 to 2019, an estimated 47,199 new cases of human papillomavirus (HPV)-associated cancers occurred in the United States each year, including 26,177 among women and 21,022 among men.

Hematologic cancers begin in the cells of the immune system or in blood-forming tissue, such as the bone marrow. This data brief provides the rate of new hematologic cancers by age at diagnosis and cancer type, 5-year relative survival by cancer type, and estimated 5-year limited duration prevalence counts by sex and cancer type.

In 2019, a total of 1,752,735 new invasive cancer cases were reported in the United States: 863,830 among females and 888,905 among males. For all cancers combined, the incidence rate was 439 per 100,000 standard population overall. It was 415 per 100,000 among females and 474 per 100,000 among males.